Ouida Westney, MD
Urology · Houston, TXNPI 1417980525
Payments from drug & device makers
Across 251 payments — averaging $517.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$118K
- AMAG Pharmaceuticals, Inc.$8K
- Axonics, Inc.$1K
- Convatec Inc.$671
- Coloplast$440
- Innovation Technologies Inc$301
- plus $1K from 12 others
Across 2 payments — averaging $2450.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Urotronic, Inc$4K
- Laborie Medical Technologies Corp.$700
What the payments were for
- Consulting fees$7,6506%
- Speaking & faculty fees$99,31377%
- Travel & lodging$10,2748%
- Food & beverage$12,57110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 200 | $118,278 |
| AMAG Pharmaceuticals, Inc. | 1 | $7,650 |
| Axonics, Inc. | 9 | $1,030 |
| Convatec Inc. | 13 | $671 |
| Coloplast | 4 | $440 |
| Innovation Technologies Inc | 2 | $301 |
| Bluewind Medical | 4 | $269 |
| Laborie Medical Technologies Corp. | 3 | $252 |
| Medtronic(2 entities) | 2 | $227 |
| Johnson & Johnson(2 entities) | 2 | $137 |
| 180 Medical, Inc. | 2 | $137 |
| Janssen Scientific Affairs, LLC | 1 | $136 |
| Urogen Pharma, Inc. | 2 | $86 |
| AbbVie | 2 | $64 |
| Astellas Pharma US Inc | 1 | $61 |
| Cook Medical LLC | 1 | $25 |
| Alafair Biosciences, Inc. | 1 | $22 |
| Exelixis Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AdVance XP$35,369
- ADVANCE$22,287
- AMS$21,048
- TACTRA$16,109
- MAKENA$7,650
- AMS 700 CXR RTE KIT$2,051
- GENERAL - THERAPIES$1,156
- Axonics$858
- GENERAL ERECTILE DYSFUNCTION$494
- AMS 800 Artificial Urinary Sphincter$463
- AMS 700$391
- TITAN$315
- GENERAL VASCULAR INTERVENTION$302
- Irrisept$301
- GENERAL MALE SUI$275
- INTERSTIM$227
- GENTLECATH$224
- GENERAL KIDNEY STONE DISEASE$136
- REVI$113
- GENERAL PELVIC ORGAN PROLAPSE$111
How this compares
$129,808 in reported general payments places this provider in the 90th percentile of 878 urology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 25 | $18,338 |
| Tramadol Hcl | 27 | $26 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $61 | $18,33825 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 878 urology providers in Texas.
Other urology in Houston
- Zvi SchiffmanHouston$17.8M
- Jose KaramHouston$5.7M
- Raj SatkunasivamHouston$2.6M
- Alan SkolnickHouston$2.4M
- Brian ChapinHouston$1.1M
- Arun RaiHouston$1M
- Ashish KamatHouston$957K
- Donald GriffithHouston$732K
- Robert CornellHouston$695K
- John DavisHouston$669K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.